An iterative process produces oxamniquine derivatives that kill the major species of schistosomes infecting humans

Currently there is only one method of treatment for human schistosomiasis, the drug praziquantel. Strong selective pressure has caused a serious concern for a rise in resistance to praziquantel leading to the necessity for additional pharmaceuticals, with a distinctly different mechanism of action,...

Descripción completa

Detalles Bibliográficos
Autores principales: Guzman, Meghan A., Rugel, Anastasia R., Tarpley, Reid S., Alwan, Sevan N., Chevalier, Frédéric D., Kovalskyy, Dmytro P., Cao, Xiaohang, Holloway, Stephen P., Anderson, Timothy J. C., Taylor, Alexander B., McHardy, Stanton F., LoVerde, Philip T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7454593/
https://www.ncbi.nlm.nih.gov/pubmed/32810153
http://dx.doi.org/10.1371/journal.pntd.0008517

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7454593/
https://www.ncbi.nlm.nih.gov/pubmed/32810153
http://dx.doi.org/10.1371/journal.pntd.0008517

Ejemplares similares